Related Experiment Videos
Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies
1Servicio de Hemoterapia y Hemostasia, Hospital Clinic, Barcelona, Spain. escolar@medicina.ub.es
Thrombosis and Haemostasis
|April 1, 2000
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Towards the understanding of the UV light, riboflavin and additive solution contributions to the in vitro lesions observed in Mirasol®-treated platelets.
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Emicizumab for routine prophylaxis to prevent bleeding episodes in patients with hemophilia A.
Drugs of today (Barcelona, Spain : 1998)·2018
Betrixaban: a direct oral inhibitor of activated factor X for the prophylaxis of venous thromboembolism in patients hospitalized for acute medical illness.
Drugs of today (Barcelona, Spain : 1998)·2017
Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies.
Drugs of today (Barcelona, Spain : 1998)·2017
Clinical Validation of a Point-of-Care Whole Blood Coagulometer in Patients on Factor Xa Inhibitors.
Thrombosis and haemostasis·2026
Rotem Platelet Component (A5 Platelet) as a Rapid Marker of Thrombocytopenia after Severe Trauma.
Thrombosis and haemostasis·2026
Phosphoproteomics identifies the DYRK1B protein kinase as a regulator of processing bodies.
Journal of cell science·2026
In Vivo and In Vitro SUMOylation Assays in Arabidopsis.
Bio-protocol·2026
Liquid-Liquid Phase Separation (LLPS) in Tumor Biology: Special Focus on the Process of Transcription.
International journal of molecular sciences·2026
Impact of Obstructive Sleep Apnea on Blood-Brain Barrier Permeability and Membrane Proteins.
International journal of molecular sciences·2026